{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:35:11Z","timestamp":1774787711518,"version":"3.50.1"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"41","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,22]]},"DOI":"10.18632\/oncotarget.6533","type":"journal-article","created":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T02:38:52Z","timestamp":1449715132000},"page":"43281-43292","source":"Crossref","is-referenced-by-count":13,"title":["Hepatitis B virus core antigen as a carrier for <i>Chlamydia trachomatis<\/i> MOMP multi-epitope peptide enhances protection against genital chlamydial infection"],"prefix":"10.18632","volume":"6","author":[{"given":"Pengfei","family":"Jiang","sequence":"first","affiliation":[{"name":"Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangqi","family":"Du","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yirong","family":"Xiong","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lv","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Feng","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanli","family":"Zhu","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Xue","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Molecular Virology and Immunology, Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, P. R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,12,9]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/jama.291.18.2229","article-title":"Prevalence of chlamydial and gonococcal infections among young adults in the United States","volume":"291","author":"Udry","year":"2004","journal-title":"JAMA"},{"key":"2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00404-013-3122-3","article-title":"Chlamydia trachomatis infection: implications for HPV status and cervical cancer","volume":"289","author":"Medeiros","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"3","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model","volume":"79","author":"Morrison","year":"2011","journal-title":"Infect Immun"},{"key":"4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/IAI.01173-08","article-title":"Chlamydia trachomatis polymorphic membrane protein D is an oligomeric autotransporter with a higher-order structure","volume":"77","author":"Caldwell","year":"2009","journal-title":"Infect Immun"},{"key":"5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2958.2000.02167.x","article-title":"Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target","volume":"38","author":"Stephens","year":"2000","journal-title":"Mol Microbiol"},{"key":"6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1099\/jmm.0.05093-0","article-title":"Chlamydial vaccine development","volume":"52","author":"Longbottom","year":"2003","journal-title":"J Med Microbiol"},{"key":"7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000024300","article-title":"Immunogenicity of neutralizing epitopes on multiple-epitope vaccines against HIV-1","volume":"121","author":"Chen","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000050037","article-title":"HBV core particles as a carrier for B cell\/T cell epitopes","volume":"44","author":"Grens","year":"2001","journal-title":"Intervirology"},{"key":"9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/erv.12.150","article-title":"Hepatitis B core-based virus-like particles to present heterologous epitopes","volume":"12","author":"Saelens","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/sti.2010.048173","article-title":"Analyses of multiple-site and concurrent Chlamydia trachomatis serovar infections, and serovar tissue tropism for urogenitalrectal specimens in male and female patients","volume":"87","author":"Meijer","year":"2011","journal-title":"Sex Transm Infect"},{"key":"11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1099\/jmm.0.008607-0","article-title":"Genotyping of Chlamydia trachomatis from the endocervical specimens of high-risk women in Hungary","volume":"58","author":"Gonczol","year":"2009","journal-title":"J Med Microbiol"},{"key":"12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10096-008-0650-z","article-title":"Chlamydia trachomatis serovar distribution and other concurrent sexually transmitted infections in heterosexual men with urethritis in Italy","volume":"28","author":"Cevenini","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/abbs\/gmq087","article-title":"Identification of immunodominant linear B-cell epitopes within the major outer membrane protein of Chlamydia trachomatis","volume":"42","author":"Zhang","year":"2010","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"14","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.173.5.3375","article-title":"A novel recombinant multisubunit vaccine against Chlamydia","volume":"173","author":"Igietseme","year":"2004","journal-title":"J Immunol"},{"key":"15","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/IAI.68.6.3074-3078.2000","article-title":"Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses","volume":"68","author":"Brunham","year":"2000","journal-title":"Infect Immun"},{"key":"16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(00)00074-0","article-title":"Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals","volume":"43","author":"Babiuk","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"17","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1128\/IAI.66.8.3618-3625.1998","article-title":"Phylogenetic analysis of the Chlamydia trachomatis major outer membrane protein and examination of potential pathogenic determinants","volume":"66","author":"Jones","year":"1998","journal-title":"Infect Immun"},{"key":"18","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1016\/j.vaccine.2009.05.008","article-title":"Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein","volume":"27","author":"de la Maza","year":"2009","journal-title":"Vaccine"},{"key":"19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2217\/17460913.3.1.67","article-title":"Vaccines for Chlamydia infections of the female genital tract","volume":"3","author":"McNeilly","year":"2008","journal-title":"Future Microbiol"},{"key":"20","first-page":"980","article-title":"Vaccines for Chlamydia trachomatis infections","volume":"3","author":"Peterson","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"21","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s00253-014-5517-x","article-title":"Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice","volume":"98","author":"Zhang","year":"2014","journal-title":"Appl Microbiol Biotechnol"},{"key":"22","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.vaccine.2010.12.132","article-title":"Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1","volume":"29","author":"Zhang","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"23","first-page":"14646","article-title":"DNA vaccines to attack cancer","volume":"101","author":"Rice","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"24","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.170.8.4273","article-title":"Identification and characterization of the immunodominant rat HER-2\/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2\/neu-transgenic mice","volume":"170","author":"Jaffee","year":"2003","journal-title":"J Immunol"},{"key":"25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/hv.4.3.5393","article-title":"Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness","volume":"4","author":"Lubitz","year":"2008","journal-title":"Hum Vaccin"},{"key":"26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/IAI.72.2.1019-1028.2004","article-title":"Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection","volume":"72","author":"Beagley","year":"2004","journal-title":"Infect Immun"},{"key":"27","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.4049\/jimmunol.169.11.6324","article-title":"GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis","volume":"169","author":"Brunham","year":"2002","journal-title":"J Immunol"},{"key":"28","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/IAI.68.12.6798-6806.2000","article-title":"Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes","volume":"68","author":"Murdin","year":"2000","journal-title":"Infect Immun"},{"key":"29","first-page":"53","article-title":"Virus-like particles for antigen delivery at mucosal surfaces","volume":"354","author":"Ross","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4161\/hv.4.1.5559","article-title":"Virus-like particles as a vaccine delivery system: myths and facts","volume":"4","author":"Noad","year":"2008","journal-title":"Hum Vaccin"},{"key":"31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/vaccines1030225","article-title":"Vector Design for Improved DNA Vaccine Efficacy, Safety and Production","volume":"1","author":"Williams","year":"2013","journal-title":"Vaccines (Basel)"},{"key":"32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/vaccines2010089","article-title":"Recent Developments in Preclinical DNA Vaccination","volume":"2","author":"Shimada","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cyto.2010.11.006","article-title":"hsBAFF regulates proliferation and response in cultured CD4(+) T lymphocytes by upregulation of intracellular free Ca(2+) homeostasis","volume":"53","author":"Chen","year":"2011","journal-title":"Cytokine"},{"key":"34","first-page":"585","article-title":"Functional heterogeneity among CD4+ T-cell clones from blood and skin lesions of leprosy patients. Identification of T-cell clones distinct from Th0, Th1 and Th2","volume":"84","author":"Frommel","year":"1995","journal-title":"Immunology"},{"key":"35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/JVI.66.1.106-114.1992","article-title":"The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity","volume":"66","author":"Milich","year":"1992","journal-title":"J Virol"},{"key":"36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/IAI.72.1.451-460.2004","article-title":"Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis","volume":"72","author":"Zhong","year":"2004","journal-title":"Infect Immun"},{"key":"37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Sette","year":"1994","journal-title":"Immunity"},{"key":"38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02788751","article-title":"The optimization of helper T lymphocyte (HTL) function in vaccine development","volume":"18","author":"Sette","year":"1998","journal-title":"Immunol Res"},{"key":"39","doi-asserted-by":"crossref","first-page":"e114155","DOI":"10.1371\/journal.pone.0114155","article-title":"The grafting of universal T-helper epitopes enhances immunogenicity of HIV-1 Tat concurrently improving its safety profile","volume":"9","author":"Ranga","year":"2014","journal-title":"PLoS One"},{"key":"40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-0934(98)00152-9","article-title":"Purification of E. coli-expressed HIS-tagged hepatitis B core antigen by Ni2+ -chelate affinity chromatography","volume":"77","author":"von Brunn","year":"1999","journal-title":"J Virol Methods"},{"key":"41","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1016\/j.febslet.2005.08.044","article-title":"assembly of mosaic hepatitis B virus capsid-like particles (CLPs): rescue into CLPs of assembly-deficient core protein fusions and FRET-suited CLPs","volume":"579","author":"Nassal","year":"2005","journal-title":"FEBS Lett"},{"key":"42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2249.1997.2511129.x","article-title":"Synthetic peptides based on Chlamydia trachomatis antigens identify cytotoxic T lymphocyte responses in subjects from a trachoma-endemic population","volume":"107","author":"Mabey","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"43","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1128\/IAI.63.9.3527-3530.1995","article-title":"Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars","volume":"63","author":"Lampe","year":"1995","journal-title":"Infect Immun"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T18:38:07Z","timestamp":1589395087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,9]]},"references-count":43,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2015,12,22]]}},"alternative-id":["6533","26657117"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6533","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,9]]}}}